Shanghai-Listed Companies Step Up Buybacks and Shareholder Increases This Year as Industrial Capital Continues to Flow In

Corporate Action
โดย 为自有资金或自筹资金·Read original
Summary · why it matters

A wave of share buybacks and shareholder increases continues to surge among companies listed on the Shanghai Stock Exchange, with the pace of industrial capital entering the market notably accelerating. Over the past week, 42 new buyback plans were added on the Shanghai market, with a maximum amount of 8.386 billion yuan, and 17 new shareholder increase plans were added, with a maximum amount of 7.457 billion yuan. Since the start of 2026, the Shanghai market has disclosed 190 new buyback plans, with a combined maximum amount reaching 55.5 billion yuan, and 155 new shareholder increase plans, with a maximum amount of 22.1 billion yuan. Many companies are making big moves. The chairman of NARI Technology proposed a buyback of 500 million to 1 billion yuan, the chairman of Daqin Railway proposed a buyback of 400 million to 500 million yuan, Sany Heavy Industry plans to buy back 400 million to 800 million yuan, and Yifeng Pharmacy Chain plans to buy back 200 million to 300 million yuan. The implementation of funds is also speeding up. Haier Smart Home has cumulatively bought back 1.817 billion yuan in this round, Seres has cumulatively bought back over 587 million yuan, Metallurgical Corporation of China has completed transactions totaling about 415 million yuan, and Chenguang Stationery has paid a total of 288 million yuan. On the shareholder increase side, the controlling shareholder of China Three Gorges Renewables plans to increase holdings by 1.5 billion to 3 billion yuan, the controlling shareholder of Aluminum Corporation of China plans to increase holdings by 1 billion to 2 billion yuan, and the controlling shareholder of China State Construction Engineering plans to increase holdings by 500 million to 1 billion yuan.

Impact on stocks 11

Others▲ · 11 stocks
Yifeng Pharmacy
603939
▲ PositiveCapitalrelevance

Yifeng Pharmacy plans a buyback of 200-300 million yuan, a capital return to shareholders.

© 2026 MarketDXNews